Overview

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

Status:
Completed

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

The objective of the proposed study is to determine whether BL-7040 demonstrates clinical efficacy in patients with inflammatory bowel disease (IBD).

Phase:

Phase 2

Details

Lead Sponsor:

BioLineRx, Ltd.